Medivir to present at the Redeye Orphan Drugs Conference
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Redeye Orphan Drugs Conference on April 27, 2022. CEO Jens Lindberg will present at 15.15 CET. The presentation is live broadcasted and can be followed at; https://www.redeye.se/events/825140/redeye-theme-orphan-drugs For additional information, please contact Magnus Christensen, CFO Telephone: +46 8 5468 3100 E-mail: magnus.christensen@medivir.com Medivir in brief Medivir